Heart Rate Changes and Metabolic Changes A notable finding in retatrutide trials is a modest increase in resting heart rate, approximately 5 to 10 beats per minute, observed during treatment, peaking around week 24 before tapering
A wave of regulatory approvals particularly for cardiovascular disease signals broader therapeutic potential, and growing optimism extends to their use in areas such as neurodegenerative disorders and addiction medicine
Unlike alternative treatments, Ipamorelin therapy does not negatively interfere with other hormones, such as prolactin and cortisol
This process is vital for enhancing blood flow and delivering necessary nutrients to damaged areas, thus supporting systemic healing and muscle regeneration
Used GLP-1 pens should be disposed of according to local NHS guidelines
Focus on technique improvement for next time rather than trying to correct it now